Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Condition:   Prostate Adenocarcinoma Intervention:   Combination Product: MVA-BN-Brachyury Sponsors:   University of Utah;   Bavarian Nordic;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials